CELIXIR LIMITED
Company number 10141208 · Active · Stratford-Upon-Avon CV37 7GZ
CELIXIR LIMITED is an active private limited company (company number 10141208) incorporated on 22 April 2016, registered in Stratford-Upon-Avon. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 April 2025, showing net assets of £1, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
By net assets it sits in the lower half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Key dates
- Incorporated
- 22 April 2016
- Next accounts due
- 30 January 2027 — in 106 days
- Confirmation statement due
- 6 May 2027 — in 202 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 30 April 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 April 2025 | £1 | — | — | £0 | — | — | 0 |
| 30 April 2024 | £1 | — | — | £0 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 68/100 (grade B)
- +10 Positive net assets — Net assets £1 at 2025-04-30
- +8 Established — Incorporated 2016-04-22 (10 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Cardiogeni Plc (corporate entity, England) — has significant influence or control; has significant influence or control · since 6 January 2025
- Cell Therapy Limited (corporate entity, Wales) — owns 75–100% of shares; holds 75–100% of voting rights; can appoint or remove directors · since 6 July 2016 · ceased 20 April 2018
- Celixir Plc (corporate entity, England) — owns 75–100% of shares; holds 75–100% of voting rights; can appoint or remove directors · since 20 April 2018 · ceased 6 January 2025
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in Coventry
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- INVICTUS BIOSCIENCES LTD — Coventry, inc. May 2016
- STEMVITA LTD — Stratford-Upon-Avon, inc. Jul 2016
- ANTIMICROBIAL DISCOVERY SOLUTIONS LIMITED — Warwick, inc. Jun 2015
- LAKSHMI SOLUTIONS LIMITED — Rugby, inc. Apr 2015
- INTRAVITALS LTD — Coventry, inc. May 2017
- ELITE BIOTECHNICAL RESEARCH AND DEVELOPMENT LIMITED — Coventry, inc. Dec 2017
Reminders for CELIXIR LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.